Ridgetech Inc（RDGT）股票分析

AI 分析 of Ridgetech Inc (RDGT)

买入

Ridgetech, Inc. appears to be a good buy right now due to its recent price increase of 36.78% yesterday and a 5-day change of 27.05%. The stock is currently trading at $1.02, which is significantly below its 52-week high of $760.50, indicating potential for recovery. The RSI is at 74.734, suggesting that the stock is overbought, but the momentum could continue given the recent bullish sentiment following the reverse stock split. However, the main risk is its extreme volatility, as evidenced by a year-to-date change of -99.74%, which highlights the potential for significant price fluctuations.

估值指标

Ridgetech Inc（RDGT）当前预期市盈率为 1.11，5 年平均预期市盈率为 9.47。

预期市盈率

合理

5 年均值 P/E

9.47

当前P/E

1.11

高估

33.88

低估

-14.93

预期 EV/EBITDA

严重低估

5 年均值 EV/EBITDA

0.00

当前EV/EBITDA

0.00

高估

0.00

低估

0.00

预期市销率

严重低估

5 年均值 P/S

0.00

当前P/S

0.00

高估

0.00

低估

0.00

Alphio AI 对 RDGT 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。

乐

乐观

乐观 · 25%RDGT

$1.29

情景价格

基

基准

基准 · 50%RDGT

$1.24

情景价格

悲

悲观

悲观 · 25%RDGT

$1.00

情景价格

RDGT 常见问题 —— 由 Alphio AI 解答

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors. It operates in the Consumer Cyclicals sector.

Ridgetech, Inc. appears to be a good buy right now due to its recent price increase of 36.78% yesterday and a 5-day change of 27.05%. The stock is currently trading at $1.02, which is significantly below its 52-week high of $760.50, indicating potential for recovery. The RSI is at 74.734, suggesting that the stock is overbought, but the momentum could continue given the recent bullish sentiment following the reverse stock split. However, the main risk is its extreme volatility, as evidenced by a year-to-date change of -99.74%, which highlights the potential for significant price fluctuations.